WBI Investments LLC Has $1.26 Million Stock Position in McKesson Corporation $MCK

WBI Investments LLC reduced its position in McKesson Corporation (NYSE:MCK) by 26.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,627 shares of the company’s stock after selling 582 shares during the period. WBI Investments LLC’s holdings in McKesson were worth $1,257,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in MCK. GGM Financials LLC acquired a new position in McKesson in the third quarter worth approximately $25,000. State of Wyoming bought a new position in McKesson during the second quarter valued at approximately $29,000. Hopwood Financial Services Inc. acquired a new stake in McKesson in the third quarter valued at approximately $31,000. Delos Wealth Advisors LLC bought a new stake in McKesson in the second quarter worth approximately $35,000. Finally, Abound Wealth Management grew its position in McKesson by 104.3% in the third quarter. Abound Wealth Management now owns 47 shares of the company’s stock worth $37,000 after acquiring an additional 24 shares in the last quarter. 85.07% of the stock is owned by hedge funds and other institutional investors.

McKesson Trading Down 0.1%

NYSE MCK opened at $942.57 on Wednesday. McKesson Corporation has a 1 year low of $637.00 and a 1 year high of $999.00. The company has a fifty day simple moving average of $898.61 and a 200 day simple moving average of $830.00. The company has a market cap of $115.45 billion, a P/E ratio of 27.11, a P/E/G ratio of 1.52 and a beta of 0.38.

McKesson (NYSE:MCK) last announced its earnings results on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, topping the consensus estimate of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The firm had revenue of $106.16 billion for the quarter, compared to the consensus estimate of $105.98 billion. During the same quarter last year, the firm posted $8.03 EPS. The business’s quarterly revenue was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Equities research analysts forecast that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be paid a dividend of $0.82 per share. The ex-dividend date is Monday, March 2nd. This represents a $3.28 annualized dividend and a yield of 0.3%. McKesson’s dividend payout ratio is presently 9.43%.

Insider Activity

In other McKesson news, EVP Leann B. Smith sold 190 shares of the firm’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $945.00, for a total value of $179,550.00. Following the sale, the executive vice president owned 2,989 shares of the company’s stock, valued at $2,824,605. This trade represents a 5.98% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Michele Lau sold 2,725 shares of McKesson stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total value of $2,697,750.00. Following the completion of the transaction, the executive vice president directly owned 3,247 shares in the company, valued at approximately $3,214,530. This represents a 45.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 3,868 shares of company stock worth $3,743,820 over the last 90 days. Company insiders own 0.08% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on MCK shares. Robert W. Baird set a $968.00 price target on shares of McKesson in a report on Wednesday, January 14th. Wall Street Zen cut shares of McKesson from a “buy” rating to a “hold” rating in a report on Saturday. TD Cowen raised their target price on McKesson from $1,000.00 to $1,012.00 and gave the company a “buy” rating in a report on Thursday, February 5th. Evercore reaffirmed an “outperform” rating on shares of McKesson in a research report on Thursday, March 5th. Finally, Wells Fargo & Company upped their price target on McKesson from $914.00 to $925.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 5th. Thirteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $960.93.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.